WeVote
Log In

Bill

Bill

HB 112

An Act relating to the Board of Pharmacy; relating to the practice of pharmacy; relating to pharmacies; relating to prescription drug manufacturers; relating to licensing and registration requirements for certain wholesale drug distributors; relating to prescriptions for epinephrine; relating to the administration of epinephrine; and providing for an effective date.

33rd Legislature (2023-2024) Introduced by Matt Claman and 10 co-sponsors

Alaska expands pharmacy oversight, requires wholesale distributor licensing, and broadens epinephrine access to non-pharmacists in emergency situations.

(H) FN2: (CED)
#advertising #boards&commissions #drugs #health&socialservices #internet #licensing #media #occupations&professions #pharmacists #regulations #salaries&allowances
0
WeVote Research Nonpartisan
Bill Summary · HB 112

Legislative bill overview

HB 112 is a comprehensive Alaska pharmacy regulation bill that modifies Board of Pharmacy oversight, pharmacy licensing requirements, wholesale drug distributor registration, and prescription/administration protocols for epinephrine auto-injectors. The bill addresses multiple aspects of pharmaceutical practice and safety, including provisions allowing broader access to emergency epinephrine administration.

Why is this important

Epinephrine access provisions can be life-saving in anaphylaxis emergencies, particularly in remote Alaska communities with limited immediate medical care. The wholesale distributor registration and licensing changes aim to strengthen supply chain oversight and reduce risks of counterfeit or diverted medications, which affects medication safety and public health infrastructure statewide.

Potential points of contention

  • Epinephrine administration scope: Expanding who can administer epinephrine (potentially non-medical personnel) raises liability and training standardization concerns, though it addresses rural healthcare gaps
  • Regulatory burden on distributors: New licensing/registration requirements for wholesale drug distributors may increase compliance costs, potentially affecting smaller operators and rural pharmacy supply chains
  • Board authority expansion: Broadening Board of Pharmacy regulatory powers could affect pharmacy practice flexibility, though proponents argue it strengthens consumer protections and quality control

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.